Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
10.35
1.17 (12.75%)
At close: Oct 15, 2025, 3:59 PM
10.35
0.00%
After-hours: Oct 15, 2025, 04:20 PM EDT
12.75% (1D)
| Bid | 10 |
| Market Cap | 795.69M |
| Revenue (ttm) | 83.69M |
| Net Income (ttm) | -244.78M |
| EPS (ttm) | -2.97 |
| PE Ratio (ttm) | -3.48 |
| Forward PE | -2.63 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.35 |
| Volume | 1,311,933 |
| Avg. Volume (20D) | 935,510 |
| Open | 9.18 |
| Previous Close | 9.18 |
| Day's Range | 9.18 - 10.43 |
| 52-Week Range | 8.18 - 29.56 |
| Beta | 2.34 |
| Ex-Dividend Date | n/a |
About NRIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Nurix Therapeutics has released their quartely earnings
on Oct 9, 2025:
Nurix Therapeutics Inc. is scheduled to release its earnings on
Jan 27, 2026,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
+8.82%
NRIX stock has given up its prior loss. Nurix Ther...
Unlock content with
Pro Subscription
6 days ago
+8.82%
Nurix Therapeutics shares are trading lower after the company reported worse-than-expected Q3 financial results.
